Zoom at a Discount: Buy for the Long Run, Respect the Headwinds

Hook & thesis

Zoom is the kind of name that looks boring until the math speaks: trading around $86.75 today, the business generates roughly $1.96 billion in free cash flow and carries a market value near $25.4 billion. That combination implies a single-digit free-cash-flow multiple and a PE in the low teens - not the frothy multiples you see across many AI darlings. For investors willing to take a measured long-term view (up to 180 trading days), Zoom represents a compelling, actionable trade where downside can be limited and upside remains meaningful.

That said, the opportunity is not free. Zoom carries exposure to regulatory pressure in Europe, an evolving competitive landscape as large platform players bundle video into broader suites, and integration/execution risk around AI initiatives. The trade here is therefore tactical: buy on the valuation and cash production today, manage risk with a clear stop, and reassess on major functional or regulatory shifts.

What Zoom does and why the market should care

Zoom provides a communications and collaboration platform used broadly across enterprises and SMBs. The product retains network effects - the more people and organizations use Zoom, the more valuable the platform becomes for meetings, webinars, and contact-center integrations. Beyond core meetings, Zoom has been positioning itself into adjacent higher-value capabilities (contact center, webinars, and AI enhancements), and it also holds a publicized equity stake in Anthropic that gives indirect exposure to fast-growing AI models and potential upside if Anthropic continues to monetize its IP.

Key fundamentals and valuation framing

Concrete numbers matter here. At approximately $25.4 billion market cap and a current price near $86.75, Zoom is trading at about 12-13x reported earnings (EPS roughly $7.06) and a price-to-sales near 5.05. The company produces roughly $1.96 billion in free cash flow annually, which implies a free-cash-flow yield of roughly 7.7% on the market cap - a healthy figure for a scaled SaaS business with positive margins and net cash characteristics embedded in its balance sheet metrics.

These numbers argue that Zoom is priced more like a mature, cash-generative software company than a high-growth SaaS growth multiple. That re-rating is not irrational: revenue growth has normalized from earlier pandemic-driven highs, and investors are assigning less premium to growth while rewarding profitability and cash generation.

Technical and market positioning context

On the tape, Zoom is trading near shorter-term moving averages: the 10-day simple moving average is roughly $86.27 and the 20-day is $89.25, with the 50-day higher near $96.83. Momentum indicators show neutral-to-modest bullish signs - RSI near 43 and a small positive MACD histogram suggest the stock is not overbought and could resume an upmove if sentiment improves. Average traded volume is elevated versus recent daily prints; two-week average daily volume is around 3.79 million shares, while the float is approximately 264.1 million shares.

Catalysts to drive upside (2-5 items)

• Anthropic-related upside: Zoom holds a meaningful equity exposure to Anthropic; continued progress there or a favorable valuation event for Anthropic could re-rate Zoom's equity stake (newsflow around Anthropic’s IPO process matters - see 06/05/2026 and 05/26/2026 headlines).
• Stronger enterprise monetization: Continued expansion in contact-center and AI-enhanced offerings could lift average revenue per user and drive margin expansion.
• Macro-driven multiple expansion: If risk-on sentiment persists and multiples compress less in the broader market, Zoom's mid-teens PE could expand back toward historical averages.
• Better-than-feared EU/regulatory outcomes: Any easing or clarifications around European digital-sovereignty initiatives would remove a discount the market applies to U.S. conferencing vendors.

Trade plan - actionable entry, stop, targets, and horizon

This is a tactical long trade sized for a balanced, risk-aware allocation.

• Entry price: $86.75 (current market)
• Stop loss: $76.00 - place the stop below a logical support cluster and above the 52-week low to limit drawdown if regulatory or execution headlines hit.
• Target price: $105.00 - captures upside from a modest multiple expansion (pe toward ~15x) plus some earnings growth and potential Anthropic-related rerating.
• Time horizon: long term (180 trading days) - allow enough runway for enterprise adoption cycles, AI integration wins to become visible in bookings, and potential third-party valuation events that could unlock the Anthropic stake value.

Rationale: the stop at $76 limits capital risk to a little under 12% from entry while giving the trade room to weather short-term noise. The target at $105 implies ~21% upside from the entry; given FCF yield near 7.7% and the potential for multiple expansion, that is a reasonable one-sided reward-to-risk for the 180-trading-day horizon.

Risks and counterarguments

Zoom is an attractive set-up, but several non-trivial risks could derail the thesis. Below I lay out the primary risks and a counterargument for why they matter.

• Regulatory / digital-sovereignty pressure (material): European governments have signaled moves to prefer domestic or non-U.S. platforms for sensitive public-sector communications. That can reduce market share in a high-value segment and pressure multiples. Counterargument: Zoom still has a significant enterprise footprint and can mitigate losses with localized deployments or partnerships; regulatory scares often take time to meaningfully erode revenues.
• Intense competition and bundling by big tech: Microsoft, Google, and Cisco can bundle video into larger suites, eroding Zoom’s standalone pricing power. If corporate buyers accept bundled alternatives, Zoom’s ARPU could shrink. Counterargument: Zoom’s network effects, integrations, and neutral-brand positioning still provide a differentiated user experience that many customers prefer, especially for large meeting and webinar use-cases.
• Execution risk on AI initiatives: Zoom is investing in AI features and commercial integrations; failing to execute or monetize these effectively would limit upside and leave the company exposed to pure-play AI vendors. Counterargument: Zoom’s stake in Anthropic and existing distribution give it a head start on embedding advanced models into its collaboration suite.
• Macro and sentiment-driven multiple compression: As a software name that once traded on growth narratives, Zoom can still suffer multiple contraction if capital markets rotate away from software. This risk can keep the stock range-bound despite solid cash generation.
• Concentration of valuation around a stake: Part of Zoom’s rerating story depends on Anthropic exposure; should that stake be revalued lower, Zoom’s apparent upside shrinks materially.

Counterargument summary: The strongest counterargument is that structural threats and regulatory moves could combine to make Zoom's steady cash flows look less durable, justifying a lower multiple. That is plausible and why position sizing and a clearly defined stop are non-negotiable.

What would change my mind

I would reduce conviction or move to a neutral stance if any of the following occur:

• Clear, coordinated regulatory actions in Europe materially reducing Zoom’s public-sector and enterprise penetration in large EU markets.
• Quarterly results showing sustained ARPU contraction or a large drop in enterprise retention/expansion metrics.
• An Anthropic valuation event that reduces the market’s valuation of Zoom’s stake materially (e.g., a down-round or forced disposal at a low price).

Conclusion

Zoom presents a practical trade today: attractive cash generation, modest multiples, and optionality via AI exposure make a long position with disciplined risk controls a reasonable play for investors with a long-term (180 trading days) time horizon. The suggested entry at $86.75 with a $76 stop and $105 target balances upside potential against identifiable downside drivers. Maintain position discipline and watch regulatory and execution headlines closely - they are the key variables that will determine whether this is a good value trap or a profitable re-rating.

Short checklist for the trade

• Entry: $86.75
• Stop: $76.00
• Target: $105.00
• Horizon: long term (180 trading days)
• Position sizing: keep exposure limited to no more than a normal allocation for a mid-risk software holding; tighten the stop or trim into strength if regulatory news worsens.

Numbers-driven buy with a guarded guardrail: attractive valuation and cash flow justify a long, but treat the trade like a project with a stop and an exit plan.